![]() |
市场调查报告书
商品编码
1389701
支链胺基酸(BCAA) 市场规模- 按类型(L-亮氨酸、L-异亮氨酸和L-缬氨酸)、应用(运动营养、食品和饮料、动物饲料、药品、化妆品和个人护理)、形式与全球预测,2023 - 2032Branched Chain Amino Acids (BCAAs) Market Size - By Type (L-Leucine, L-Isoleucine, and L-Valine), Applications (Sports Nutrition, Food and Beverage, Animal Feed, Pharmaceuticals, Cosmetics and Personal Care), Form & Global Forecast, 2023 - 2032 |
由于电子商务通路日益占据主导地位,可以轻鬆在线获取各种产品,全球支链氨基酸 (BCAA) 市场规模预计在 2023 年至 2032 年期间CAGR为 5.8%。
为了满足不同的喜好并增强消费者的整体体验,一些支链胺基酸供应商正在专注于创新,推出新的配方和口味。对引入新的输送形式(例如粉末、胶囊和饮料)的大力重视也将促进市场的成长。举个例子,2021 年 10 月,英国快速成长的运动营养品牌 Applied Nutrition 推出了新系列 BCAA 胺基酸水合物饮料,装在 330 毫升碳酸罐中,以扩大其随身携带系列。
整个支链胺基酸产业根据类型、形式、应用和地区进行细分。
就类型而言,2023-2032年L-缬氨酸市场规模的CAGR可能为6.3%。 L-缬氨酸天然存在于多种富含蛋白质的食物中,例如肉类、乳製品和豆类。为此,它被广泛用作膳食补充剂,与其他支链氨基酸结合使用,以满足蛋白质需求增加和特定健身目标的个人。肝功能调节以及伤口癒合和组织修復的重要性日益提高也将有利于产品需求。
根据应用,到 2032 年,製药领域的支链胺基酸市场规模预计将以 6.4% 的成长率扩大。这可以归因于药物配方中的支链胺基酸含量不断增加,为面临挑战的患者提供营养支持。透过定期饮食摄取充足的蛋白质。随着癌症和慢性阻塞性肺病 (COPD) 等慢性疾病负担的日益加重,蛋白质合成中对支链氨基酸(尤其是亮氨酸)的需求不断增加,以帮助维持肌肉量。
从地区来看,由于健康和健身意识不断增强以及对运动营养的强烈关注,欧洲支链氨基酸行业规模预计从 2023 年到 2032 年将以 5.8% 的CAGR增长。
植物性产品的新兴趋势推动了植物性饮食的日益普及,推动了对源自豌豆、大豆和其他植物性蛋白质的植物性支链胺基酸的需求不断增长。多个电子商务平台的便利性和广泛的产品选择也将有助于区域产品的吸收。
Global Branched Chain Amino Acids (BCAAs) Market size is poised to record 5.8% CAGR from 2023-2032, due to the growing dominance of e-commerce channels to render ease of access to wide range of products online.
To match the diverse preferences and enhance the overall experiences of consumers, several BCAA providers are focusing on innovations for introducing new formulations and flavors. The robust emphasis on introducing new delivery formats, such as powders, capsules, and drinks will also compliment the market growth. To cite an instance, in October 2021, the U.K.-based fast-growing sports nutrition brand Applied Nutrition introduced a new line of its BCAA amino-hydrate drinks in a 330ml carbonated can for expanding its On-the-go range.
The overall BCAAs industry is segmented based on type, form, application, and region.
In terms of type, the market size from the L-valine segment may observe 6.3% CAGR from 2023-2032. L-valine is naturally found in several protein-rich foods, such as meat, dairy products, and legumes. To that end, it is widely used as a dietary supplement in combination with other BCAAs to cater to individuals with increased protein needs and specific fitness goals. Rising importance in the regulation of liver function as well as wound healing and tissue repair will also prove favorable for the product demand.
On the basis of application, the branched chain amino acids market size from the pharmaceuticals segment is expected to expand at 6.4% growth rate up to 2032. This can be ascribed to the rising inclusion in pharmaceutical formulations to provide nutritional support for patients facing challenges in consuming adequate protein through regular dietary intake. With the growing burden of chronic illnesses, such as cancer and chronic obstructive pulmonary disease (COPD), the demand for BCAAs, especially leucine is increasing in protein synthesis to help preserve muscle mass.
Regionally, the Europe BCAAs industry size is projected to accrue 5.8% CAGR from 2023 to 2032 due to the increasing awareness of health and fitness along with the strong focus on sports nutrition.
The growing popularity of plant-based diets driven by the emerging trend of plant-based products is pushing the increasing demand for plant-based BCAAs sourced from peas, soy and other plant proteins. The ease of access to convenience and wide range of product choices in multiple e-commerce platforms will also contribute to the regional product uptake.